Clay Siegall is a scientist, author, and exceptional corporate leader.

Clay Siegall is a scientist, author, and exceptional corporate leader.

Clay Siegall is a phenomenal leader, a trained scientist and a philanthropist with his focus mainly on research and developing pharmaceuticals to alleviate the pain for cancer patients. Clay Siegall is the co-founder of Seattle Genetics and currently serving as the chairman of the board, the President of the company, and Chief Executive Officer. Seattle Genetics was launched in 1998 with a vision of employing innovative practices in drug development and research focusing on the needs of the patients. Much of credit is pointed towards Clay Siegall for overseeing the company through their FDA approval of the flagship drug a product of antibody-drug conjugate (ADC), ADCETRIC. Also, Seattle Genetics entered into an alliance with Takeda Pharmaceutical Company, and their partnership has led to the drug ADCETRIS to be an international brand approved across over 65 countries in the world. Another significant leap that the company has taken under the watch of Clay Siegall is the calculated multiple licensing of their ADC technology. The move to acquire various licensing for ADC generated for Seattle Genetics more than $350 million and still counting. Clay Siegall also vehemently led the capital raising activities for Seattle Genetics raising over $1.2 billion using strategies such as private and public funding and the company going public in 2001. Clay Siegall has worked in the pharmaceutical industry for an extended period especially those venturing in the field of oncology. Bristol-Myers Squibb Institute of Pharmaceutical Research and the National Institute of Health and Cancer are among the places Clay Siegall has previously worked. The work and efforts of Clay Siegall have been recognized over the years, and he has received numerous awards one of the outstanding of all is the University of Maryland Alumnus of the Year Award. Clay Siegall was presented with the merits for Computer, Math and Natural Sciences for the year 2013. Clay Siegall holds 15 patents under his name and has also written more than 70 publications. Clay Siegall though his outstanding educational background having got his Ph.D. in the field of genetics from the University of George Washington, he remains a humble man and tries to learn new things.